Bridge Laboratories

Bridge Laboratories is a preclinical Contract Research Organization (CRO) that provides drug development services meeting U.S. regulatory requirements on a global scale. Bridge Laboratories is U.S.-owned, with its headquarters in Gaithersburg, Maryland, and laboratories located in both the U.S. and Beijing, China. The company is well-known for its extensive work in toxicology, including vaccines, Developmental and Reproductive Toxicology (DART), and safety pharmacology. Bridge's AAALAC-accredited facility in China was among the first laboratories to conduct GLP studies for global clients.